Devin Donnelly, PharmD

A four-week course of glecaprevir/pibrentasvir achieved sustained virologic response in 84% of patients with early hepatitis C infection in the PURGE-C trial, suggesting potential for shorter, more accessible treatment regimens pending further validation. contagionlive.com/view/is-4-week…

@_JuliaRx Posa ppx and venetoclax 100mg. Really never see a bad LFT rise with that.

Polling #oncopharm what anti-fungal prophylaxis strategy does your institution utilize in AML induction (intensive and non-intensive)? Do you avoid azoles or make dose reductions on days venetoclax is given? Would love to hear what other centers are doing!

Honored 😎 @ashinetobacter @W_DePasquale

🆕️⚡️ @AJHPOfficial Cost evaluation of continuation of therapy with dalbavancin compared to standard-of-care antibiotics alone in hospitalized persons who inject drugs with severe gram-positive infections #IDXposts #PWID academic.oup.com/ajhp/advance-a…

Poster 625 at #SHEASpring2023: Do you have FOMO (fear of missing organisms)? If your patient with a diabetic foot infection has not had a culture with Pseudomonas in the past year, this has a negative predictive value of 94%. Hold on the pip-tazo!

Amoxicillin is amazing drug — don’t be afraid to push the dose to 1000 mg PO q6h- 100% target attainment for Streptococci. Check out this extremely cool paper recently published and shared by Dr. Jim Lewis at #SHEASpring2023 @SHEA_Epi pubmed.ncbi.nlm.nih.gov/36947131/

🚨 New Post 🚨 Here are my TOP 🔟 journal articles for infectious diseases pharmacy rotations 🤔 Have fun one not listed? Share the link and let us know why you 😁love it! #IDtwitter #Medtwitter #TwitteRx 📲 idstewardship.com/top-10-journal…

🆕️⚡️ @antibioticsmdpi Real-World Budget Impact of Fidaxomicin versus Vancomycin or Metronidazole for In-Hospital Treatment of CDI Despite higher fidaxomicin drug costs, overall cost savings were estimated at GBP 140,292 (GBP 2125 per CDI #IDTwitter mdpi.com/2079-6382/12/1…

Hot take: the amount of Louis Vuitton and YSL bags I’ve seen at midyear is a blatant reminder that being here is a privilege. To the RPDs out there, please don’t discount applicants that couldn’t afford to be here with us.

Congrats to our previous PGY-2 ID residents, @ashinetobacter and @AlysaMartinRX , for the recent publication of their flipped-model research project evaluating clinical outcomes of nCP-CRE compared with carbapenem-susceptible Enterobacterales infections tinyurl.com/bdfxt5bm

🙏

Got this great mug from my PGY1 co-resident today! Great start to my first week as an ID PGY2 ☕️ 💊

Officially a proud graduate of the RGH PGY1 pharmacy residency! Could not be more excited to start training in infectious diseases at URMC 🤩😎